Stuart E. Needleman
Keine laufenden Positionen mehr
Profil
Stuart Needleman has been Vice President of Sales and Marketing for Aptuit, Inc. since March, 2006.
Previously, he was Senior Director of Sales and Marketing for Aptuit.
Mr. Needleman was Vice President of Business Development for ChiRex, Inc., General Manager of Development Operations for Rhodia Pharma Solutions Ltd., and President of North America for Arch Pharmalabs Ltd.
He worked with Cambrex Corp.
and Oxford Asymmetry International Plc.
Mr. Needleman has more than 20 years experience in drug development, with a specialization in the global development, scale-up, and manufacture of regulated active pharmaceutical ingredients (API) for new and established compounds.
Mr. Needleman received his MBA and BSc degrees in Chemical Engineering from the Rensselaer Polytechnic Institute.
Ehemalige bekannte Positionen von Stuart E. Needleman
| Unternehmen | Position | Ende |
|---|---|---|
| Oxford Asymmetry International Plc | Corporate Officer/Principal | - |
| CAMBREX CORPORATION | Corporate Officer/Principal | - |
Arch Pharmalabs Ltd.
 Arch Pharmalabs Ltd. Pharmaceuticals: MajorHealth Technology Arch Pharmalabs Ltd. manufactures and sells pharmaceutical products. Its therapeutic segments include side chains of Semi-Synthetic Isoxazole Penicillins under Antibiotics, Lipid Lowering Agents, Oncology, Anti-Platelet Agents, Anti-Asthmatic, Anti-Retroviral, Decongestant, Anti-Herpes, Anti-Malarial, NSAIDs and Anti-Anginal segments. The company was founded in 1975 and is headquartered in Mumbai, India. | Präsident | - |
Rhodia Pharma Solutions Ltd.
 Rhodia Pharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Rhodia Pharma Solutions Ltd. manufactures pharmaceutical products. The company was founded on August 26, 1965 and is headquartered in Watford, the United Kingdom. | Corporate Officer/Principal | - |
| ChiRex, Inc. | Corporate Officer/Principal | - |
Ausbildung von Stuart E. Needleman
| Rensselaer Polytechnic Institute | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
| ChiRex, Inc. | Health Technology |
Aptuit LLC
 Aptuit LLC Miscellaneous Commercial ServicesCommercial Services Aptuit LLC engages in the development of pharmaceutical and biotechnological products. Its offerings include drug design and discovery, preclinical biosciences, API development and manufacture, solid state chemistry, solid and oral dosage form development and manufacture, integrated drug discovery and drug development, Aptuit INDiGO, and physical and analytical chemistry services. The company was founded in December 2004 and is headquartered in Greenwich, CT. | Commercial Services |
| Oxford Asymmetry International Plc | Process Industries |
Rhodia Pharma Solutions Ltd.
Rhodia Pharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Rhodia Pharma Solutions Ltd. manufactures pharmaceutical products. The company was founded on August 26, 1965 and is headquartered in Watford, the United Kingdom. | Health Technology |
Arch Pharmalabs Ltd.
Arch Pharmalabs Ltd. Pharmaceuticals: MajorHealth Technology Arch Pharmalabs Ltd. manufactures and sells pharmaceutical products. Its therapeutic segments include side chains of Semi-Synthetic Isoxazole Penicillins under Antibiotics, Lipid Lowering Agents, Oncology, Anti-Platelet Agents, Anti-Asthmatic, Anti-Retroviral, Decongestant, Anti-Herpes, Anti-Malarial, NSAIDs and Anti-Anginal segments. The company was founded in 1975 and is headquartered in Mumbai, India. | Health Technology |
